🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a multicenter, Phase I, open-label, randomized, 2-sequence, 2...
Status
Completed
Location
Research Site
Start Date
2021-02-25
Trial ID
NCT04768985
Treatments Being Tested
This study is being conducted to support the clinical development of acalab...
Status
Completed
Location
Research Site
Start Date
2020-05-22
Trial ID
NCT04435483
Treatments Being Tested
Study Phase III Randomized Study to Investigate the Use of Acalabrutinib in...
Status
Completed
Location
Hospital de la Santa Creu i Sant Pau
Start Date
2019-12-09
Trial ID
NCT04178798
Treatments Being Tested
This study will evaluate the effect of fluconazole and isavuconazole on the...
Status
Completed
Location
Celerion
Start Date
2020-01-03
Trial ID
NCT05140096
Treatments Being Tested
This study is to evaluate the effects of single therapeutic and supratherap...
Status
Completed
Location
Celerion
Start Date
2016-04-01
Trial ID
NCT04867980
Treatments Being Tested
This Phase 1 study is being conducted to support the clinical development o...
Status
Completed
Location
Research Site
Start Date
2020-10-12
Trial ID
NCT04564040
This study will be a 2-part, open-label, single-center relative bioavailabi...
Status
Completed
Location
Research Site
Start Date
2020-06-24
Trial ID
NCT04488016
The purpose of this study is to test a combination treatment of acalabrutun...
Status
Terminated
Location
University of Miami
Start Date
2020-09-22
Trial ID
NCT04189952
Treatments Being Tested
The STELLAR trial will assess the effect of acalabrutinib taken in combinat...
Status
Active Not Recruiting
Location
Belfast City Hospital
Start Date
2019-07-23
Trial ID
NCT03899337
Treatments Being Tested
NCCN guidelines for B cell lymphoma suggest that patients with relapsed/ref...
Status
Completed
Location
Seoul National University Hospital
Start Date
2019-07-09
Trial ID
NCT04094142
Treatments Being Tested